Follow-up Results After Scanning
| Patient no. | Follow-up results |
| 1 | Started bicalutamide and leuprolide, and PSA decreased from 18.7 to 2.53; follow-up MRI showed decreased size and number of retroperitoneal lymph nodes |
| 2 | Chose to have no treatment, and PSA increased from 8.6 to 10.9 |
| 3 | Started bicalutamide and leuprolide, and PSA decreased from 36.4 to 2.2 |
| 4 | Started no treatment yet, and PSA increased from 6.7 to 12.1; on biopsy, 12 prostate cores were negative and right vas deferens showed metastatic adenocarcinoma (Gleason 4 + 3; 15% of core) |
| 5 | Started no treatment yet, and PSA increased from 8.53 to 10.2 |
| 6 | Started bicalutamide, and PSA decreased from 7.36 to 0.38 |
| 7 | Started bicalutamide, and PSA decreased from 18.2 to 2.5 |